GSK to buy Sierra Oncology amid pressure to boost drug pipeline

GSK to buy Sierra Oncology amid pressure to boost drug pipeline

Source: 
Reuters
snippet: 
  • GSK paying 39% premium in cash for Sierra
  • U.S. biotech's main experimental drug treats rare blood cancer
  • GSK under pressure to boost drug pipeline
  • British drugmaker preparing to spin off consumer products ops